Author: Brian Mattmiller

Could pre-existing conditions hold the clue to new COVID-19 drugs?

The deadliest cases of COVID-19 often arise in patients with a variety of pre-existing conditions, known to medicine as “comorbidity.” A Morgridge Institute for Research project will investigate those disease relationships in the search for new drug treatments.

Using nanobodies to fish for coronavirus clues

A Morgridge Institute for Research project intended to shed light on planarians — remarkable flatworms capable of almost limitless regeneration — is being repurposed to focus on the novel coronavirus causing COVID-19.

Chronicling pandemic science in real time

Morgridge virology investigator Anthony Gitter, an assistant professor of biostatistics and medical informatics at UW–Madison, has co-developed a software tool called Manubot to help orchestrate a rapid expert assessment of COVID-19 diagnostics and therapeutics.